Depression Home > Fetzima Dosage

For people with major depression, the recommended starting dosage of Fetzima is 20 mg once a day for two days. After that, your amount may be increased to 40 mg a day. If symptoms are still not under control, your dose may be further increased slowly to a maximum of 120 mg daily. If you have kidney problems, you may need a lower amount.


An Introduction to Dosing With Fetzima

The dose of Fetzima™ (levomilnacipran) your healthcare provider recommends will vary, depending on a number of factors, including:
  • How you respond to Fetzima
  • Other medications you are taking
  • Other medical conditions you may have.
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.

What Is the Recommended Fetzima Dosage?

The usual recommended starting dose of Fetzima for treating major depression is 20 mg once daily for two days. After two days, the dose will be increased to 40 mg a day.
Your healthcare provider may choose to increase your dose further, based on how you respond to and tolerate the medication. If this amount is increased, it will normally be by 40 mg at a time, no more often than every two days. Amounts above 120 mg a day are not recommended.
You should know that it can take several weeks, if not more than a month, for this medication to work completely. Therefore, your healthcare provider may recommend you continue taking Fetizma even if it does not seem to be working right away.

Fetzima Dose for People With Kidney Disease

People with moderate kidney disease should generally not receive more than 80 mg of Fetzima a day. For people with severe kidney disease, the maximum recommended dosage is 40 mg a day. This drug is not recommended for use in people with end-stage kidney disease.
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.